Mountain View Clinical Research, Inc

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Depression3 trials
• Obstructive sleep apnoea2 trials
• Coeliac disease1 trial

Phase

• Phase 34 trials
• Phase 22 trials
• Phase 2/31 trial

Status

• Completed3 trials
• Recruiting2 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Apnimed2 trials
• Definium Therapeutics US, Inc.2 trials
• atai Therapeutics, Inc.1 trial
• Biohaven Pharmaceuticals, Inc.1 trial
• Chugai Pharmaceutical1 trial

Running trials

• Recruiting

  A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

  NCT07592689· Phase 3· Definium Therapeutics US, Inc.· Source

  Contact: Jessica Bryant

• Recruiting

  Study of DONQ52 in Active Celiac Disease

  NCT07239336· Phase 2· Chugai Pharmaceutical· Source

• Active, not recruiting

  A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)

  NCT06941844· Phase 3· Definium Therapeutics US, Inc.· Source

• Enrolling by invitation

  Continuation Protocol for Obstructive Sleep Apnea (OSA)

  NCT06566820· Phase 3· Apnimed· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coeliac disease1 recruiting
• Depression1 recruiting
• Obstructive sleep apnoea1 recruiting

Closed trials

• Completed

  A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  NCT06524830· Phase 2· atai Therapeutics, Inc.· Source

• Completed

  Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

  NCT05811247· Phase 3· Apnimed· Source

• Completed

  Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder

  NCT03299166· Phase 2/3· Biohaven Pharmaceuticals, Inc.· Source